Treosulfan-TMI Conditioning and Rapamycin GvHD Prophylaxis Before Allo-HSCT

NCT03963024 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped low rate of enrolment

Conditions

Irradiated Bone Marrow
Transplant-Related Hematologic Malignancy
Leukemia, Acute
Multiple Myeloma
Graft Vs Host Disease

Interventions

DRUG: Conditioning treatment "Treosulfan-TMI"
PROCEDURE: SCT
DRUG: GvHD prophylaxis

Sponsor

IRCCS San Raffaele